ANGO | AngioDynamicsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$11.76
-$0.23 (-1.92%)

AngioDynamics (ANGO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jun 2026, but the two have been closing on each other and a death cross is projected within 30 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
between the two $11.99 vs 50 $12.42 / 200 $9.63
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 23 Feb 2026 ยท projected 17 bars out ยท tested 7 bars

4-hour as of 3 Nov 13:30 ET

Price
below both $12.00 vs 50 $12.59 / 200 $14.01
Projection
No cross projected
Test
No active test
Last cross
Death cross 20 Oct 2026 ยท projected 18 bars out

Cross history

36
crosses on record since 2017
19 golden17 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
20 Oct 2026Death4-hour18 bars outNot tested
25 Jun 2026Golden moderatedaily12 bars outNot tested
19 May 2026Golden4-hour16 bars outNot tested
13 Mar 2026Death steepdaily12 bars out5 bar cross test
week of 23 Feb 2026Golden flatweekly17 bars out7 bar cross test

About ANGO

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$7.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.